David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $235,480.9
Shares · price: 9,890 sh · $23.81 a share
Held after: 57,095 sh
Stock: Mineralys Therapeutics MLYS
Person: David Malcom RodmanChief Medical Officer
Trade date: 26/06/15
Filed: 26/06/17
Days to filing: 2 days

Sold 14.8% of holdings

Share of holding sold: 14.8%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 05/16~07/15

David Malcom Rodman's recent trades

David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$11.7K
417 sh
$11.7K
Filed 09/17
Traded 09/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$216.9K
7,709 sh
$216.9K
Filed 09/14
Traded 09/14
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$67K
2,171 sh
$67K
Filed 09/09
Traded 09/09
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$10.6K
417 sh
$10.6K
Filed 08/17
Traded 08/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$372.2K
14,056 sh
$372.2K
Filed 08/13
Traded 08/13

David Malcom Rodman, Chief Officer — sold $235.5K of Mineralys Therapeutics MLYS · 14.8% of holdings · 10b5-1 plan | Whalegun